Data Snapshot: Aug 04, 2026
<$50K

Jul-2026

Sales

Decline

Trend

6-Month

15

Product Count

SKUs

$18.32

Avg Price

-36%

YoY Sales Change

10.2%

YoY Price Change

OM is a prominent brand in the medical cannabis industry, known for its persistent efforts to deliver high-quality, FDA-approved medical cannabis backed by ample knowledge and cutting-edge technology. With a decade-long approval from the MOH, OM exhibits a thorough commitment to public health and safety through rigorous standards and secure practices. Engaging advanced technology and gaining insightful knowledge from multiple sources, OM bridges the gap between medical necessity and cannabis use while providing trustworthy health information.
OM

Where to Buy

OM is stocked at 29 licensed dispensaries across California, with the deepest coverage in San Francisco, Santa Rosa, Healdsburg, Los Angeles, and Cameron Park. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/1922.json?v=20260804
OM Sales

Market Insights Snapshot

OM Historical Sales by Category

OM’s mix in July 2026 is fully concentrated in Topical at 100.0% share, with category sales down 31.30% year over year and 29.42% month over month; against this contraction, the brand-level sales decline of 35.99% year over year indicates the single-category exposure amplified the slump rather than buffering it. Average price rose 10.22% year over year to $18.32 while sales fell, a combination that points to price/mix not offsetting volume losses; in parallel, the Topical rank in California sat at 12, implying mid-pack placement that did not prevent a near-30% month-over-month retreat. The pattern implies OM’s one-category dependence left it over-indexed to Topical softness in July 2026, where price increases coincided with volume pressure and a mid-tier rank that offered limited insulation against demand swings.

With 100.0% of sales in Topical and a California rank of 12, the 31.30% year-over-year and 29.42% month-over-month declines suggest the brand’s positioning is anchored to a segment under short-term demand pressure rather than diversified across steadier categories; the 35.99% brand sales decline exceeding Topical’s year-over-year drop signals incremental brand-specific headwinds within the category. The 10.22% average price lift alongside a near-30% month-over-month sales contraction indicates price elasticity or reduced promotional depth likely weighed on velocity, and being outside the top 10 compounds visibility challenges during a downturn. The implication is that near-term positioning hinges on recalibrating price/pack or distribution within Topical to regain velocity while evaluating selective category adjacencies to dilute volatility from single-category exposure.

Jul-2026 Rank
Topical
12
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Topical
100.0%
$18.32
-31.3%
-29.4%
OM

Competitive Landscape

OM sits at #12 in California Topical for July 2026, down 1 rank from #11 year over year, and also slipped 2 positions from #10 in April 2026 to #12 in July 2026, while peaking at #8 in May 2026; by contrast, Papa & Barkley held at #1 year over year as Liquid Flower climbed from #6 to #4, indicating that OM is losing relative placement while faster-moving rivals are consolidating top-tier positions; the pattern implies OM’s trajectory is trending sideways-to-down, and without rank recovery from #12 toward the prior #8 peak, competitive visibility will keep compressing against leaders.

OM market ranking for CA Topical

OM

Notable Products

CBD/THC 1:4 Arnica Balm (100mg CBD, 420mg THC, 2oz) posted the standout Month-over-Month movement in July 2026 with +94.8% and climbed to rank 8, while CBN/THC 1:5 Lavender Sweet Dreams Rosin Bath Bomb (50mg THC, 10mg CBN, 2.85oz) fell -52.5% to rank 9. At the top, CBD/THC 1:1 Rose Geranium Epsom Salt (25mg THC, 25mg CBD, 6.5oz) rose +13.9% to hold rank 1 as the Arnica Relief Bath Bomb (100mg) slid -48.7% at rank 3, signaling a shift from bombs toward therapeutic balms and salts. With all ten top SKUs concentrated in Topical and two Epsom Salt variants sitting in the top four despite -27.2% and -35.0% declines on sister items, the portfolio is consolidating around multi-cannabinoid recovery formats rather than single-experience bath bombs. The pattern implies OM is migrating demand toward targeted relief use-cases where price-per-dose and repeat utility drive choice, even as volatility among bath bombs pressures breadth.

Product
Category
Mar-2026
Apr-2026
May-2026
Jun-2026
Jul-2026
MoM %
CBD/THC 1:1 Rose Geranium Epsom Salt (25mg THC, 25mg CBD, 6.5oz)
Topical
8
4
7
4
1
+13.9%
CBD/THC 1:1 Recovery Epsom Bath Salts (25mg CBD, 25mg THC, 6.5oz)
Topical
3
6
5
1
2
-34.8%
Arnica Relief Bath Bomb (100mg)
Topical
1
1
2
1
3
-48.7%
CBD/THC 1:1 Arnica Pain Relief Epsom Bath Salts (25mg CBD, 25mg THC)
Topical
4
3
4
2
4
-27.2%
CBD/THC 1:1 Lavender Epsom Bath Salts (25mg CBD, 25mg THC, 6.5oz)
Topical
2
7
3
3
4
-35.0%
Just Peachy Rosin Bath Bomb (100mg)
Topical
1
2
1
3
5
-34.5%
CBD/THC 1:4 Love Balm (100mg CBD, 420mg THC, 2oz)
Topical
6
7
4
3
6
-43.5%
CBN/THC 1:10 Sweet Dreams Bath Bomb (100mg THC, 10mg CBN)
Topical
10
>10
10
5
7
-17.4%
CBD/THC 1:4 Arnica Balm (100mg CBD, 420mg THC, 2oz)
Topical
9
5
>10
8
8
+94.8%
CBN/THC 1:5 Lavender Sweet Dreams Rosin Bath Bomb (50mg THC, 10mg CBN, 2.85oz)
Topical
8
8
8
6
9
-52.5%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market